{"id":"https://openalex.org/W153036019","doi":"https://doi.org/10.1182/blood.v88.2.633.bloodjournal882633","title":"The novel anthracycline annamycin is not affected by P-glycoprotein- related multidrug resistance: comparison with idarubicin and doxorubicin in HL-60 leukemia cell lines","display_name":"The novel anthracycline annamycin is not affected by P-glycoprotein- related multidrug resistance: comparison with idarubicin and doxorubicin in HL-60 leukemia cell lines","publication_year":1996,"publication_date":"1996-07-15","ids":{"openalex":"https://openalex.org/W153036019","doi":"https://doi.org/10.1182/blood.v88.2.633.bloodjournal882633","mag":"153036019","pmid":"https://pubmed.ncbi.nlm.nih.gov/8695811"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v88.2.633.bloodjournal882633","doi":"https://doi.org/10.1182/blood.v88.2.633.bloodjournal882633","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood.v88.2.633.bloodjournal882633","pdf_url":"https://ashpublications.org/blood/article-pdf/88/2/633/844468/633.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ashpublications.org/blood/article-pdf/88/2/633/844468/633.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102992884","display_name":"Ugo Consoli","orcid":"https://orcid.org/0009-0002-0249-3411","observed_orcids":["https://orcid.org/0009-0002-0249-3411"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"U Consoli","raw_affiliation_strings":["Department of Hematology, University of Texas, M.D. Anderson Cancer Center, Houston, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, University of Texas, M.D. Anderson Cancer Center, Houston, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062959791","display_name":"Waldemar Priebe","orcid":"https://orcid.org/0000-0003-4522-4772","observed_orcids":["https://orcid.org/0000-0003-4522-4772","https://orcid.org/0000-0003-3969-0144"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W Priebe","raw_affiliation_strings":["Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston, USA","Experimental Therapeutics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston, USA","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Experimental Therapeutics","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005501231","display_name":"YH Ling","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"YH Ling","raw_affiliation_strings":["Department of Hematology, University of Texas, M.D. Anderson Cancer Center, Houston, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, University of Texas, M.D. Anderson Cancer Center, Houston, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069286758","display_name":"R Mahadevia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R Mahadevia","raw_affiliation_strings":["Department of Hematology, University of Texas, M.D. Anderson Cancer Center, Houston, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, University of Texas, M.D. Anderson Cancer Center, Houston, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007843401","display_name":"Mary S. Griffin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M Griffin","raw_affiliation_strings":["Department of Hematology, University of Texas, M.D. Anderson Cancer Center, Houston, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, University of Texas, M.D. Anderson Cancer Center, Houston, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087322136","display_name":"Shuchun Zhao","orcid":"https://orcid.org/0000-0003-0462-768X","observed_orcids":["https://orcid.org/0000-0003-0462-768X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S Zhao","raw_affiliation_strings":["Department of Hematology, University of Texas, M.D. Anderson Cancer Center, Houston, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, University of Texas, M.D. Anderson Cancer Center, Houston, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108481953","display_name":"Roman Perez-Soler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R Perez-Soler","raw_affiliation_strings":["Department of Hematology, University of Texas, M.D. Anderson Cancer Center, Houston, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, University of Texas, M.D. Anderson Cancer Center, Houston, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079262854","display_name":"Michael Andreeff","orcid":"https://orcid.org/0000-0002-1144-1958","observed_orcids":["https://orcid.org/0000-0002-1144-1958"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M Andreeff","raw_affiliation_strings":["Department of Hematology, University of Texas, M.D. Anderson Cancer Center, Houston, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, University of Texas, M.D. Anderson Cancer Center, Houston, USA","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.8975,"has_fulltext":true,"cited_by_count":48,"citation_normalized_percentile":{"value":0.74801721,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"88","issue":"2","first_page":"633","last_page":"644"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1313","display_name":"Molecular Medicine"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anthracyclines","display_name":"anthracyclines","score":0.949999988079071},{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.8130000233650208},{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.9679999947547913},{"id":"https://openalex.org/keywords/mdr1","display_name":"MDR1","score":0.9150000214576721},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.8309999704360962},{"id":"https://openalex.org/keywords/idarubicin","display_name":"idarubicin","score":1.0},{"id":"https://openalex.org/keywords/hl-60-cells","display_name":"HL-60 cells","score":0.8889999985694885},{"id":"https://openalex.org/keywords/verapamil","display_name":"verapamil","score":0.9039999842643738},{"id":"https://openalex.org/keywords/drug-accumulation","display_name":"drug accumulation","score":0.7379999756813049},{"id":"https://openalex.org/keywords/drug-survival","display_name":"drug retention","score":0.8429999947547913},{"id":"https://openalex.org/keywords/resistive-index","display_name":"resistance index","score":0.6019999980926514},{"id":"https://openalex.org/keywords/leukemia-chemotherapy","display_name":"leukemia chemotherapy","score":0.3149999976158142}],"concepts":[{"id":"https://openalex.org/C2779117419","wikidata":"https://www.wikidata.org/wiki/Q1063862","display_name":"Idarubicin","level":4,"score":0.846268892288208},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.7676551342010498},{"id":"https://openalex.org/C2778707650","wikidata":"https://www.wikidata.org/wiki/Q412902","display_name":"P-glycoprotein","level":4,"score":0.7087209224700928},{"id":"https://openalex.org/C133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","level":3,"score":0.5955366492271423},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5541109442710876},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.5007455348968506},{"id":"https://openalex.org/C2776802502","wikidata":"https://www.wikidata.org/wiki/Q417589","display_name":"Anthracycline","level":4,"score":0.4990527629852295},{"id":"https://openalex.org/C2781021840","wikidata":"https://www.wikidata.org/wiki/Q411659","display_name":"Daunorubicin","level":3,"score":0.48544222116470337},{"id":"https://openalex.org/C200082930","wikidata":"https://www.wikidata.org/wiki/Q22327148","display_name":"Efflux","level":2,"score":0.47397416830062866},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.39643779397010803},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.39464446902275085},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.3843512237071991},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3455541729927063},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.28102564811706543},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2472563087940216},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.22848045825958252},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.19835227727890015},{"id":"https://openalex.org/C2778041864","wikidata":"https://www.wikidata.org/wiki/Q180983","display_name":"Cytarabine","level":3,"score":0.195153146982193},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.10776928067207336},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000903","descriptor_name":"Antibiotics, Antineoplastic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000903","descriptor_name":"Antibiotics, Antineoplastic","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009363","descriptor_name":"Neoplasm Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014700","descriptor_name":"Verapamil","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015255","descriptor_name":"Idarubicin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018432","descriptor_name":"Drug Resistance, Multiple","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018922","descriptor_name":"HL-60 Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018922","descriptor_name":"HL-60 Cells","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020168","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1182/blood.v88.2.633.bloodjournal882633","doi":"https://doi.org/10.1182/blood.v88.2.633.bloodjournal882633","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood.v88.2.633.bloodjournal882633","pdf_url":"https://ashpublications.org/blood/article-pdf/88/2/633/844468/633.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmid:8695811","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8695811","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Comparative Study"}],"best_oa_location":{"id":"doi:10.1182/blood.v88.2.633.bloodjournal882633","doi":"https://doi.org/10.1182/blood.v88.2.633.bloodjournal882633","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood.v88.2.633.bloodjournal882633","pdf_url":"https://ashpublications.org/blood/article-pdf/88/2/633/844468/633.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.5,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1727840030","display_name":null,"funder_award_id":"CA-16 672","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G1929583504","display_name":null,"funder_award_id":"CA-55164","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G331047307","display_name":null,"funder_award_id":"CA 55 320","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G3774884214","display_name":"THE THERAPY OF AML","funder_award_id":"P01CA055164","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G4066496856","display_name":null,"funder_award_id":"CA50270","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G6572243137","display_name":"ANNAMYCIN--MECHANISMS OF ACTION","funder_award_id":"5r01ca050270-07","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G712306758","display_name":"TARGET SPECIFICITIES OF DEAMINATED ANTHRACYCLINES","funder_award_id":"5r01ca055320-03","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W153036019.pdf","grobid_xml":"https://content.openalex.org/works/W153036019.grobid-xml"},"referenced_works_count":52,"referenced_works":["https://openalex.org/W70444494","https://openalex.org/W107098111","https://openalex.org/W329750643","https://openalex.org/W1015192920","https://openalex.org/W1538846621","https://openalex.org/W1543426834","https://openalex.org/W1571215201","https://openalex.org/W1586763410","https://openalex.org/W1776168062","https://openalex.org/W1958840615","https://openalex.org/W1963732225","https://openalex.org/W1974030182","https://openalex.org/W1989970027","https://openalex.org/W1990961958","https://openalex.org/W1995119934","https://openalex.org/W1996966081","https://openalex.org/W2001412380","https://openalex.org/W2011895842","https://openalex.org/W2012431622","https://openalex.org/W2018652769","https://openalex.org/W2027690665","https://openalex.org/W2028533496","https://openalex.org/W2030686317","https://openalex.org/W2034486771","https://openalex.org/W2037431338","https://openalex.org/W2037705779","https://openalex.org/W2040342801","https://openalex.org/W2042134248","https://openalex.org/W2048557817","https://openalex.org/W2057609259","https://openalex.org/W2070038334","https://openalex.org/W2083102892","https://openalex.org/W2118069529","https://openalex.org/W2125205754","https://openalex.org/W2125692928","https://openalex.org/W2130199714","https://openalex.org/W2134812217","https://openalex.org/W2135923360","https://openalex.org/W2140802667","https://openalex.org/W2153712534","https://openalex.org/W2155259473","https://openalex.org/W2157407457","https://openalex.org/W2167991144","https://openalex.org/W2168070336","https://openalex.org/W2185332252","https://openalex.org/W2229146067","https://openalex.org/W2279816465","https://openalex.org/W2287550164","https://openalex.org/W2416456508","https://openalex.org/W2418320614","https://openalex.org/W3111650914","https://openalex.org/W4214502457"],"related_works":["https://openalex.org/W7061063665","https://openalex.org/W2087604811","https://openalex.org/W1982652854","https://openalex.org/W2008559715","https://openalex.org/W2065723669","https://openalex.org/W2044128437","https://openalex.org/W2035998254","https://openalex.org/W2165096142","https://openalex.org/W2037468006","https://openalex.org/W2045032952"],"abstract_inverted_index":{"A":[0,16],"major":[1],"factor":[2],"in":[3,66,110,117,133,215,221,260,264],"limiting":[4],"the":[5,12,55,67,118,151,179,216,265],"efficacy":[6],"of":[7,11,60,108,120,205,218,227,248,267],"anthracyclines":[8],"is":[9,23,279],"overexpression":[10],"MDR1-encoded":[13],"p-glycoprotein":[14],"(p-gp).":[15],"new":[17],"analogue":[18],"less":[19,167],"affected":[20,47,281],"by":[21,48,53,186,197,282],"p-gp":[22],"annamycin":[24],"(ANN),":[25],"an":[26],"anthracycline":[27,157],"antibiotic":[28],"with":[29,80,97,128,159],"high":[30],"affinity":[31],"for":[32,258],"lipid":[33],"membranes":[34],"and":[35,58,64,74,81,137,171,207,212,223,229,251,276],"significantly":[36],"more":[37],"activity":[38],"than":[39,93,169,203],"doxorubicin":[40],"(DOX).":[41],"We":[42],"investigated":[43],"whether":[44],"ANN":[45,123,142,146,164,233,278],"was":[46,124,201],"p-gp-mediated":[49,243,283],"multidrug":[50],"resistance":[51,190],"(MDR)":[52],"comparing":[54],"cellular":[56],"accumulation":[57],"retention":[59,132,139,143],"ANN,":[61,250],"idarubicin":[62],"(IDR),":[63],"DOX":[65,91,131,170,208,228,252,259,275],"p-gp-negative":[68],"human":[69],"leukemia":[70],"cell":[71,184],"lines":[72],"(HL-60S)":[73],"its":[75,189],"DOX-selected":[76],"p-gp-positive":[77],"subline":[78],"(HL-60/DOX)":[79],"without":[82],"verapamil":[83],"(VER).":[84],"As":[85],"expected,":[86],"HL-60/DOX":[87,134,261],"cells":[88,135,195,262],"showed":[89,253],"lower":[90,202],"uptake":[92,102,109,114],"HL-60S":[94,111],"cells;":[95],"coincubation":[96],"VER":[98,129,219],"(10":[99],"mmol/L)":[100],"increased":[101,115,130],"2.6-fold":[103],"restoring":[104],"it":[105],"to":[106,154,165,241],"100%":[107],"cells.":[112],"IDR":[113,138,172,206],"1.5-fold":[116],"presence":[119,217,266],"VER,":[121],"but":[122,188],"not":[125,235,280],"affected.":[126],"Coincubation":[127,214],"2.8-fold":[136],"1.4-fold;":[140],"unchanged":[141],"indicated":[144],"that":[145,182,204],"may":[147],"overcome":[148],"p-gp.":[149],"In":[150,173],"cytotoxicity":[152],"assay":[153],"correlate":[155],"intracellular":[156,255],"content":[158],"antitumor":[160],"activity,":[161],"we":[162],"found":[163],"be":[166],"potent":[168],"sensitive":[174,199],"cells,":[175],"ID":[176],"50":[177],"being":[178],"drug":[180,256],"concentration":[181],"inhibits":[183],"growth":[185],"50%":[187],"index":[191],"(RI;":[192],"ID50":[193,198],"resistant":[194],"divided":[196],"cells)":[200],"(2.6":[209],"v":[210],"40":[211],"117.5).":[213],"resulted":[220],"4.5-fold":[222],"2-fold":[224],"RI":[225],"decreases":[226],"IDR,":[230,249,277],"respectively,":[231],"whereas":[232],"did":[234],"change,":[236],"further":[237],"confirming":[238],"ANN's":[239],"ability":[240],"circumvent":[242],"MDR.":[244,284],"Confocal":[245],"microscopy":[246],"studies":[247],"higher":[254],"compartmentalization":[257],"incubated":[263],"VER.":[268],"This":[269],"study":[270],"provided":[271],"evidence":[272],"that,":[273],"unlike":[274]},"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}